ULTA BEAUTY, INC.

ULTA

CIK 0001403568 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$3.90B
↑+11.8% +$411Mvs FY2025 (Q1)
Operating Income
$477M
↓-7.6% -$39Mvs FY2025 (Q1)
Net Income
$357M
↓-9.3% -$37Mvs FY2025 (Q1)
Gross Profit
$1.48B
↑+11.2% +$150Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
55/100
  • Profitability
    100ROIC 43.8% (10% = solid, 20%+ = moat)
  • Liquidity
    46Current Ratio 1.41 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    100Asset Turnover 1.91x (1.0+ = capital-efficient)
  • Growth
    56Revenue YoY +11.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    27Op Margin 12.2% · trend -1.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ULTA's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -3.0%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$331.37
Total enterprise IV
$14.91B
Diluted shares
0.04B
Terminal PV
$10.51B (70% of total)
Year-5 FCF
$1.24B
YearProjected FCFDiscounted PV
+1$1.10B$1000M
+2$1.13B$936M
+3$1.17B$877M
+4$1.20B$821M
+5$1.24B$769M
Terminal$16.92B$10.51B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$435M
investment in PP&E
Dividends paid (TTM)
cash returned to holders
Stock buybacks (TTM)
$901M
share count reduction
Stock-based comp (TTM)
$17M
non-cash dilution

Balance sheet · 2026-01-31

latest filed snapshot
Total assets
$7.00B
everything owned
Total liabilities
$4.20B
everything owed
Stockholders' equity
$2.80B
shareholder claim
Net debt
$376M
LT debt minus cash

Recent performance · 65 quarters

Revenue↑+11.8% +$411M
$3.90B
Net Income↓-9.3% -$37M
$357M
Free Cash Flow↑+2.7% +$26M
$989M
Operating Margin↓-2.6pts
12.2%

Drill down